(Q73689184)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Mechanism of histamine release induced by levofloxacin, a fluoroquinolone antibacterial agent (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Mori K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Maru C

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Takasuna K

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Furuhama K

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

394

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

51-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

Safety of intravenous ciprofloxacin. A review

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Activation of exocytosis by the heterotrimeric G protein Gi3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Exocytosis in mast cells by basic secretagogues: evidence for direct activation of GTP-binding proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

The effect of alkaline earth cations on the release of histamine from rat peritoneal mast cells treated with compound 48/80 and peptide 401

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

IgE and IgGa antibody-mediated release of histamine from rat peritoneal cells. I. Optimum conditions for in vitro preparation of target cells with antibody and and challenge with antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Natural polyamines stimulate G-proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

The mast cell response to substance P: effects of neuraminidase, limulin, and some novel synthetic peptide antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Human and rat cutaneous mast cells: involvement of a G protein in the response to peptidergic stimuli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. II. Dermovascular permeability-increasing effect and action on peritoneal mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Histamine-releasing properties of T-3762, a novel fluoroquinolone antimicrobial agent in intravenous use. I. Effects of doses and infusion rate on blood pressure, heart rate and plasma histamine concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Flush induced by fluoroquinolones in canine skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Agents that Release Histamine from Mast Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Characterization of histamine release induced by fluoroquinolone antibacterial agents in-vivo and in-vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Histamine-releasing effect of a corticotrophin derivative II. Mechanism of action of histamine release by C 44 680-Ba, compared with that of Cpd. 48/80, dextran and triton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Worldwide clinical data on efficacy and safety of ciprofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Tolerance of ciprofloxacin at injection site, systemic safety and effect on electroencephalogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Tolerance of Intravenously Administered Ciprofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

In vitro activity of DR-3355, an optically active ofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900147-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(00)00147-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10771034%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference